Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
|
|
16.
|
|
|
17.
|
|
|
18.
|
|
|
19.
|
|
|
20.
|
Cost-Effectiveness of Ribociclib plus Letrozole Versus Palbociclib plus Letrozole and Letrozole Monotherapy in the First-Line Treatment of Postmenopausal Women with HR+/HER2- Advanced or Metastatic Breast Cancer: A U.S. Payer Perspective. [electronic resource] by
- Mistry, Rohit
- May, Jessica R
- Suri, Gaurav
- Young, Kate
- Brixner, Diana
- Oderda, Gary
- Biskupiak, Joseph
- Tang, Derek
- Bhattacharyya, Subrata
- Mishra, Dinesh
- Bhattacharyya, Devarshi
- Dalal, Anand A
Producer: 20181010
In:
Journal of managed care & specialty pharmacy vol. 24
Availability: No items available.
|